Advertisement

Topics

Q BioMed Inc. Announces Development Partnership with Sphaera Pharma

05:10 EDT 22 Sep 2017 | PharmPro

Sphaera Pharma will employ its proprietary and patented platform to produce a novel analog that aims to reduce or eliminate potential side effects and can reduce the amount of product a young autism patient needs to take daily.
Contributed Author: 
Q BioMed Inc.

Original Article: Q BioMed Inc. Announces Development Partnership with Sphaera Pharma

NEXT ARTICLE

More From BioPortfolio on "Q BioMed Inc. Announces Development Partnership with Sphaera Pharma"

Quick Search
Advertisement
 

Relevant Topic

Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...